| Date | Time | Source | Headline | Symbol | Company |
| 07/11/2024 | 4:00PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:LLY | Eli Lilly and Co |
| 07/10/2024 | 1:19PM | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NYSE:LLY | Eli Lilly and Co |
| 07/10/2024 | 8:40AM | Edgar (US Regulatory) | Form 8-K - Current report | NYSE:LLY | Eli Lilly and Co |
| 07/10/2024 | 6:42AM | IH Market News | Microsoft and Apple Exit OpenAI Board, TSMC Exceeds Forecasts with Record Revenue, and Other Key Updates | NYSE:LLY | Eli Lilly and Co |
| 07/09/2024 | 4:00PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:LLY | Eli Lilly and Co |
| 07/09/2024 | 6:54AM | IH Market News | BP Slashes Profit Forecast by $700 Million; Morgan Stanley Predicts S&P 500 10% Drop, and More News | NYSE:LLY | Eli Lilly and Co |
| 07/08/2024 | 4:00PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:LLY | Eli Lilly and Co |
| 07/08/2024 | 7:14AM | Edgar (US Regulatory) | Form SC TO-C - Written communication relating to an issuer or third party | NYSE:LLY | Eli Lilly and Co |
| 07/08/2024 | 6:45AM | PR Newswire (US) | Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease | NYSE:LLY | Eli Lilly and Co |
| 07/08/2024 | 6:37AM | IH Market News | Paramount-Skydance $28B Merger, Boeing Agrees to Plead Guilty with $243.6M Fine, and More News | NYSE:LLY | Eli Lilly and Co |
| 07/03/2024 | 6:59AM | IH Market News | Apple Joins OpenAI Board, Logitech President Opts Out of Reelection, and More News | NYSE:LLY | Eli Lilly and Co |
| 07/02/2024 | 1:35PM | PR Newswire (US) | Lilly's Kisunla™ (donanemab-azbt) Approved by the FDA for the Treatment of Early Symptomatic Alzheimer's Disease | NYSE:LLY | Eli Lilly and Co |
| 06/25/2024 | 10:00AM | PR Newswire (US) | Lilly collaborates with OpenAI to discover novel medicines to treat drug-resistant bacteria | NYSE:LLY | Eli Lilly and Co |
| 06/24/2024 | 11:30AM | PR Newswire (US) | Lilly Declares Third-Quarter 2024 Dividend | NYSE:LLY | Eli Lilly and Co |
| 06/24/2024 | 7:00AM | IH Market News | UPS Divests Coyote Logistics in $1.025 Billion Deal with RXO, Under Armour Agrees to $434 million Settlement, and More News | NYSE:LLY | Eli Lilly and Co |
| 06/21/2024 | 3:49PM | PR Newswire (US) | Lilly's tirzepatide reduced obstructive sleep apnea (OSA) severity, with up to 51.5% of participants meeting the criteria for disease resolution | NYSE:LLY | Eli Lilly and Co |
| 06/18/2024 | 4:23PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:LLY | Eli Lilly and Co |
| 06/18/2024 | 4:22PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:LLY | Eli Lilly and Co |
| 06/18/2024 | 4:20PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:LLY | Eli Lilly and Co |
| 06/18/2024 | 4:19PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:LLY | Eli Lilly and Co |
| 06/18/2024 | 4:17PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:LLY | Eli Lilly and Co |
| 06/18/2024 | 4:00PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:LLY | Eli Lilly and Co |
| 06/17/2024 | 4:00PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:LLY | Eli Lilly and Co |
| 06/14/2024 | 2:49PM | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NYSE:LLY | Eli Lilly and Co |
| 06/11/2024 | 4:00PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:LLY | Eli Lilly and Co |
| 06/11/2024 | 7:11AM | IH Market News | FDA Panel Supports Eli Lilly’s Donanemab, Rio Tinto Expands Stake in Boyne Smelters, and More News | NYSE:LLY | Eli Lilly and Co |
| 06/10/2024 | 4:00PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:LLY | Eli Lilly and Co |
| 06/08/2024 | 9:03AM | PR Newswire (US) | Lilly's tirzepatide was superior to placebo for MASH resolution, and more than half of patients achieved improvement in fibrosis at 52 weeks | NYSE:LLY | Eli Lilly and Co |
| 06/07/2024 | 4:00PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:LLY | Eli Lilly and Co |
| 06/07/2024 | 2:03PM | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NYSE:LLY | Eli Lilly and Co |